The cheapest statin in 2026: generic prices, drug by drug

Statins are the most-prescribed drug class in America, and, for most people, among the cheapest. More than 90 million U.S. adults take one to lower LDL cholesterol and cut cardiovascular risk. The good news for anyone paying cash is that nearly the entire class has gone generic, and several common statins cost less than a fast-food meal for a month's supply. The trap is assuming every statin is cheap. One of them, pitavastatin, can run more than fifty times the price of its classmates if you fill the brand at retail without checking alternatives first.

This guide prices all seven statins marketed in the United States, ranks them by cash cost without insurance, and answers the questions people actually search: which statin is cheapest, how atorvastatin and rosuvastatin compare on price, why pitavastatin costs so much, and whether the Zypitamag brand-discount program beats generic pitavastatin calcium. Where a number could move, we hedge it and point you to the primary source. For the broader picture of why some cholesterol drugs and other chronic-care medications carry specialty-tier prices, this article links up to our specialty pharmacy cost guide, the hub for this series.

01 / 08What is a statin, and why are most of them cheap?

A statin is a member of the HMG-CoA reductase inhibitor class. These drugs block an enzyme the liver uses to make cholesterol, which lowers circulating LDL and reduces the long-term risk of heart attack and stroke. They are chronic maintenance medications, meaning most patients take them daily for years, so the per-month price compounds quickly across a lifetime of treatment.

The reason most statins are inexpensive is simple: their patents expired long ago, and the FDA has approved multiple competing generic manufacturers for nearly every molecule in the class. When several manufacturers can legally make the same drug, cash prices collapse toward the cost of production. You can confirm whether a true marketed generic exists for any statin in the FDA Orange Book, the federal listing of approved drug products and their generic equivalents (each one approved through an ANDA). Every statin priced in this article has at least one marketed generic on file, which is what makes the single-digit prices possible.

That alignment between potency and price is the most important fact in this whole comparison. For most patients, the statin a clinician would reach for first on clinical grounds, atorvastatin or rosuvastatin, is also the one that costs almost nothing out of pocket. The expensive statins are not expensive because they work better. They are expensive for reasons of branding and generic-market dynamics, which we unpack in the pitavastatin section.

It helps to understand why generic competition drives prices down so hard. When a drug is under patent, one company holds an exclusive right to make it, so it sets whatever price the market will bear. Once that patent expires and the FDA approves abbreviated applications from rival manufacturers, several companies sell the identical molecule at once and undercut each other. Within a few years of broad generic entry, the cash price of a high-volume small-molecule drug like a statin typically falls more than 90 percent from its branded peak. That is exactly the story for atorvastatin (Lipitor went generic in 2011) and rosuvastatin (Crestor followed a few years later). Both are now manufactured by many competing makers, which is why neither costs more than a few dollars a month. The single statin where this race-to-the-bottom has not fully played out is pitavastatin, and that gap is the whole reason it remains the outlier.

02 / 08What does each statin cost in 2026?

Each statin's cash price is set mostly by how many generic makers compete for it, not by how well it works. Below is the full class, ranked from cheapest to most expensive by cash price for a 30-day supply at a common maintenance dose. The generic figures reflect discount-coupon pricing (GoodRx and SingleCare published ranges) and Cost Plus Drugs transparent pricing as of May 30, 2026. Brand figures are cash retail. Because these numbers move with pharmacy, ZIP code, and date, treat every one as approximate and verify the live price before you fill.

The spread is striking. Five statins sit under roughly $20 per month as generics. Fluvastatin runs higher mainly because it is prescribed far less often, so generic competition and pharmacy stocking are thinner. Pitavastatin is the genuine outlier: its brand, Livalo, lists above $237 per month, while the generic pitavastatin calcium runs around $37 with a coupon, still the most expensive generic in the class by a wide margin. Atorvastatin and rosuvastatin anchor the cheap end, frequently available at $4 retail programs and through Cost Plus Drugs for single-digit totals after the standard cost-plus-markup formula.

The visual below charts those same generic cash prices so the outlier is impossible to miss. It is built directly from the table above.

03 / 08Atorvastatin vs rosuvastatin cost: is there a real difference?

The atorvastatin-versus-rosuvastatin comparison is the most common head-to-head search in the statin world, and for cash-payers the answer is reassuring: the price difference between the two generics is small enough to be a rounding error. Both are high-intensity statins, both have long-established generics from multiple manufacturers, and both routinely land in the single-digit-dollar range per 30-day supply. Atorvastatin is often a dollar or two cheaper because it is prescribed more heavily and stocked more widely, but at this price level the gap is not a reason to pick one over the other.

The clinically relevant difference is potency at a given dose, not price. Rosuvastatin is somewhat more potent milligram for milligram, so a clinician might choose it to hit an LDL target at a lower dose, or pick atorvastatin for its longer track record and broader dosing flexibility. Either way, both are available at $4 retail discount programs and through Cost Plus Drugs at the transparent manufacturer-cost-plus-15-percent formula, where the total after the pharmacy fee and shipping typically still lands in single digits for a month, and even less per month on a 90-day fill. You can also compare both live with our drug price check tool before you choose a pharmacy.

Where the price can actually diverge is at the dose level, and this trips up people who compare the two drugs by name alone. The strengths are not equivalent between molecules: rosuvastatin 10 mg is roughly comparable in LDL-lowering to atorvastatin 20 mg, not to atorvastatin 10 mg. So if you are price-checking, compare the doses your clinician actually prescribed rather than assuming the milligram numbers line up. Both still land in single digits at most pharmacies, but the cheapest specific strength can flip between the two from one pharmacy to the next, which is why we recommend pricing your exact prescribed dose rather than trusting a generic "atorvastatin is cheaper" rule of thumb.

04 / 08Why is pitavastatin so expensive when other statins are not?

Pitavastatin is the statin that surprises people at the pharmacy counter, the one molecule in the class that has not become a commodity generic. Brand Livalo (pitavastatin calcium) lists above $237 for a 30-day supply, and a separate brand, Zypitamag (pitavastatin magnesium), occupies the same clinical niche. By contrast, every other statin in this article is a cheap generic. So why does this one cost so much more?

Three factors explain it. First, pitavastatin came to market later than the other statins, so its patent protection ran longer and generic competition arrived more recently. Second, even now that generic pitavastatin calcium exists, fewer manufacturers make it than make atorvastatin or simvastatin, so the price has not collapsed the way it does when a dozen makers compete. Third, the brands lean on the molecule being marketed as gentler on certain drug interactions, which sustains a premium for patients who fill the brand without checking the generic. The result is that even the generic, around $37 with a coupon, is the priciest generic statin, while the brand sits in a different universe entirely.

The practical takeaway is that pitavastatin is the one statin where you must actively shop. Generic pitavastatin calcium in the 1 mg, 2 mg, and 4 mg strengths is carried by Mark Cuban Cost Plus Drugs at its transparent cost-plus pricing, and runs around $37 with a GoodRx coupon at retail. We could not scrape the live Cost Plus price in this pass, so confirm the exact figure on the Cost Plus product page before relying on it. The important thing is that nobody paying cash should fill brand Livalo at $237 when a generic at roughly a sixth of that price exists.

Pitavastatin is the one statin where the brand-versus-generic decision is worth real money. The other six are cheap no matter what. This one punishes the patient who does not check. , RxGrab editorial summary, May 2026

05 / 08How does Zypitamag pricing work, and does it beat the generic?

Zypitamag is a brand-name pitavastatin that breaks the usual brand-versus-generic logic. It is the magnesium salt of pitavastatin, but its manufacturer distributes it through a direct, flat-rate discount program rather than the usual high retail markup. Through that program, run via the mail-order pharmacy Marley Drug, Zypitamag has been cited at roughly $34.50 to $39 per month as a cash price, far below brand Livalo and roughly in line with, or slightly below, generic pitavastatin calcium.

Treat that Zypitamag figure as a program price to verify, not a guarantee. Flat-rate brand-discount programs change their terms, and the exact dollar amount and supply length should be confirmed on the program page at the time you fill. We were able to confirm the broad $30 to $40 range but recommend you verify the specific $34.50 number directly before relying on it. The structural point stands: for pitavastatin specifically, a brand-discount program can be price-competitive with the generic, which almost never happens elsewhere in the statin class.

Why does a manufacturer ever choose to undercut itself this way? The logic is volume. Pitavastatin is a small slice of the statin market because the cheap generics own most of it, so a brand that prices itself near the generic, rather than at the $237 retail level, can win cash-paying patients who would otherwise never touch it. For you, the practical effect is that the pitavastatin decision is genuinely a three-way comparison, not the usual two-way brand-versus-generic call. You have brand Livalo at full retail (avoid), generic pitavastatin calcium at roughly $37 with a coupon or through Cost Plus, and the Zypitamag flat-rate program in the mid-$30s. The two cheaper options are close enough that the right pick can come down to which pharmacy you already use and whether you prefer the calcium or magnesium salt your clinician specified.

A note on the two salts, because the names confuse people. Livalo is pitavastatin calcium; Zypitamag is pitavastatin magnesium. They are different salt forms of the same active pitavastatin, used at the same milligram strengths, and a clinician will specify which one is appropriate. Do not assume you can freely swap one for the other at the counter the way you would swap brand atorvastatin for generic atorvastatin; the salt form is part of the prescription, so ask the pharmacist before assuming the cheaper salt is an option for you.

06 / 08How do you actually pay the lowest price for any statin?

Paying the lowest statin price comes down to four repeatable levers, and they apply whether you are filling cheap atorvastatin or pricey pitavastatin. The playbook is short because the class is so heavily generic.

Lever one, confirm a true generic exists, then never pay brand. For six of the seven statins this is automatic, the generic is the default fill. For pitavastatin, you have to ask for generic pitavastatin calcium by name, because the brand Livalo is what gets dispensed if you do not. The FDA Orange Book confirms which generics are marketed. Generic substitution is the single largest lever in this class, often a 90-percent-plus saving versus the brand.

Lever two, compare cash-discount platforms. Free coupon programs like GoodRx and SingleCare, and the transparent-pricing Cost Plus Drugs, frequently beat both insurance copays and sticker cash prices on generics. For a deeper look at how Cost Plus calculates its prices and where it wins, see our Cost Plus Drugs review. Because these prices vary by pharmacy and ZIP code, price your specific drug and dose on more than one before you commit.

Lever three, ask for a 90-day supply. Statins are lifelong maintenance drugs, so a 90-day fill lowers both the per-month cost and the number of dispensing fees you pay across a year. On a commodity generic this can shave the effective monthly price below the already-low 30-day figure.

Lever four, use patient assistance only where a generic does not solve the problem. For statins, generics solve almost everything, so PAPs are rarely needed. They matter far more for the high-cost brand-only drugs covered in our specialty pharmacy cost guide. The contrast is instructive: a statin is the textbook case of generics doing all the work, while a true specialty drug is the case where they cannot.

A common mistake is to assume your insurance copay automatically beats these cash options. For cheap generics, that is frequently false. A plan's flat generic copay might be $10 or $15, while the GoodRx or Cost Plus cash price for the same atorvastatin is $4 to $8. Because cash-discount programs cannot legally be combined with insurance on the same fill, you sometimes have to choose, and for a low-cost generic the cash price often wins outright. It is worth pricing the cash option even when you have coverage, then using whichever is lower. The catch most patients miss: paying cash means the spend does not count toward your deductible, so if you are close to meeting a deductible for other reasons, running the statin through insurance can still make sense. For a deeper breakdown of when cash beats a copay, see our cost guide series.

Finally, do not overlook where you fill. The same generic statin at the same dose can carry meaningfully different cash prices across pharmacies in the same town, because each pharmacy sets its own usual-and-customary price and accepts different discount-card networks. Big-box and warehouse pharmacies, mail-order, and the transparent online players like Cost Plus tend to anchor the low end; some chain pharmacies post surprisingly high cash sticker prices that only a coupon brings down. The five-minute habit that saves the most money is simple: before your first fill of a new statin, price your exact drug and dose at two or three nearby pharmacies plus one mail-order option, then take the prescription wherever the number is lowest.

07 / 08Where do statins fit on the specialty-cost map?

Statins sit at the opposite end of the cost map from the drugs that genuinely are expensive, and seeing the contrast explains why this class is cheap. A specialty drug is defined by cost and complexity, not by what condition it treats. A biologic is the classic specialty case. Under CMS rules, the Medicare Part D specialty-tier cost threshold sits at $950 per 30-day ingredient cost for plan years 2024 and 2025, raised from $830 in prior years. Drugs that clear that bar are expensive for structural reasons: high acquisition cost, biologic or complex molecules, limited-distribution requirements, and little or no generic competition.

Statins fail every one of those tests, which is exactly why they are cheap. They are small, simple molecules; they are manufactured by many competing generic makers; they need no special handling; and they are dispensed at any retail pharmacy. The single statin that drifts toward the expensive end, pitavastatin, does so only because of thinner generic competition, not because it is structurally a specialty drug. Contrast that with a true oral specialty medication where the brand can run thousands of dollars a month and the generic, when one finally arrives, is the only thing that brings the price back to earth.

That distinction is the whole point of this series. Some drugs are cheap because the generic market did its job. Others stay expensive until a generic arrives, and a few have no generic at all yet. If you want to understand the high-cost end of the spectrum, where patient assistance and specialty pharmacies actually matter, start with the specialty pharmacy cost guide and the difference between generic and brand-name drugs. Statins are the easy case. The hard cases are where real money is at stake.

08 / 08Who should not simply chase the cheapest statin?

Chasing the cheapest statin is a sound move for most people, because the class is generic and well understood, but a few groups should let clinical factors lead instead of price. One: patients with significant drug interactions, certain statins (notably simvastatin and lovastatin) interact with common medications and grapefruit at higher doses, so the cheapest pick is not always the safest one. Two: patients who had muscle symptoms on a prior statin, where a clinician may deliberately choose a different molecule or lower dose regardless of cost. Three: patients with liver disease or who are pregnant or breastfeeding, for whom statins may be contraindicated or need specialist oversight entirely.

For everyone else, the message is simple and good: statins are one of the rare drug classes where the clinically strong choice and the cheap choice are usually the same choice. Confirm the generic, compare two cash platforms, ask about a 90-day supply, and the costliest statin (pitavastatin) drops from $237 to roughly $35, while the rest of the class barely registers on your budget.

Want the science behind why lowering LDL matters and how cholesterol drugs work in the body? Our network site Health Britannica covers cholesterol and statin science in plain-language depth, the clinical companion to this pricing guide.